PARKMAN HEALTHCARE PARTNERS LLC Holdings

PARKMAN HEALTHCARE PARTNERS LLC is an investment fund managing more than 351.74M US dollars. The largest holdings include United Therapeutics, UnitedHealth Group Incorporated and Danaher. In Q3 2022 the fund bought assets of total value of 124.65M US dollars and sold assets of total value of 44.45M US dollars.

$351.73M

portfolio value

+0.78%

quarter

-32.84%

1 year

PARKMAN HEALTHCARE PARTNERS LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2020	37784000	159894000
Q2 2020	146105000	24119000
Q3 2020	87762000	57009000
Q4 2020	102629000	88892000
Q1 2021	115197000	89152000
Q2 2021	129499000	86175000
Q3 2021	62467000	131022000
Q4 2021	119588000	68630000
Q1 2022	57867000	157198000
Q2 2022	57089000	127243000
Q3 2022	124650000	44451000

PARKMAN HEALTHCARE PARTNERS LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology United Therapeutics Corporation Portfolio share: 4.90% Portfolio value: 17.22M Avg. open price: $173.05 Current price: $273.72 P/L: +58.17% Sold -10.39% shares Q3 2022	share	4.90%	17.22M	$173.05	$273.72	+58.17%	Sold -10.39% shares Q3 2022
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 3.97% Portfolio value: 13.96M Avg. open price: $336.63 Current price: $535.04 P/L: +58.94% Sold -4.06% shares Q3 2022	share	3.97%	13.96M	$336.63	$535.04	+58.94%	Sold -4.06% shares Q3 2022
Diagnostics & Research Danaher Corporation Portfolio share: 3.89% Portfolio value: 13.69M Avg. open price: $237.91 Current price: $267.97 P/L: +12.64% Bought +37.80% shares Q3 2022	share	3.89%	13.69M	$237.91	$267.97	+12.64%	Bought +37.80% shares Q3 2022
Medical Devices Boston Scientific Corporation Portfolio share: 3.83% Portfolio value: 13.47M Avg. open price: N/A Current price: $45.42 P/L: N/A N/A Q3 2022	share	3.83%	13.47M	N/A	$45.42	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 3.54% Portfolio value: 12.46M Avg. open price: $100.35 Current price: $124 P/L: +23.57% Bought +37.17% shares Q3 2022	share	3.54%	12.46M	$100.35	$124	+23.57%	Bought +37.17% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 3.24% Portfolio value: 11.40M Avg. open price: N/A Current price: $369.29 P/L: N/A N/A Q3 2022	share	3.24%	11.40M	N/A	$369.29	N/A	N/A Q3 2022
Healthcare Plans CVS Health Corporation Portfolio share: 3.19% Portfolio value: 11.21M Avg. open price: $92.66 Current price: $102.01 P/L: +10.09% Bought +119.68% shares Q3 2022	share	3.19%	11.21M	$92.66	$102.01	+10.09%	Bought +119.68% shares Q3 2022
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 3.04% Portfolio value: 10.70M Avg. open price: $43.52 Current price: $38.98 P/L: -10.43% Bought +38.81% shares Q3 2022	share	3.04%	10.70M	$43.52	$38.98	-10.43%	Bought +38.81% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 2.82% Portfolio value: 9.90M Avg. open price: $157.68 Current price: $121.22 P/L: -23.13% Sold -5.52% shares Q3 2022	share	2.82%	9.90M	$157.68	$121.22	-23.13%	Sold -5.52% shares Q3 2022
Medical Instruments & Supplies Haemonetics Corporation Portfolio share: 2.44% Portfolio value: 8.57M Avg. open price: $70.07 Current price: $84.71 P/L: +20.90% Bought +363.19% shares Q3 2022	share	2.44%	8.57M	$70.07	$84.71	+20.90%	Bought +363.19% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 2.33% Portfolio value: 8.20M Avg. open price: $70.09 Current price: $44.6 P/L: -36.37% Bought +72.50% shares Q3 2022	share	2.33%	8.20M	$70.09	$44.6	-36.37%	Bought +72.50% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 2.28% Portfolio value: 8.03M Avg. open price: $16.01 Current price: $38.83 P/L: +142.49% Sold -24.43% shares Q3 2022	share	2.28%	8.03M	$16.01	$38.83	+142.49%	Sold -24.43% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 2.22% Portfolio value: 7.81M Avg. open price: N/A Current price: $522.34 P/L: N/A Sold -3.12% shares Q3 2022	share	2.22%	7.81M	N/A	$522.34	N/A	Sold -3.12% shares Q3 2022
Biotechnology Avid Bioservices, Inc. Portfolio share: 2.20% Portfolio value: 7.74M Avg. open price: $11.25 Current price: $15.39 P/L: +36.76% Sold -12.23% shares Q3 2022	share	2.20%	7.74M	$11.25	$15.39	+36.76%	Sold -12.23% shares Q3 2022
Biotechnology Concert Pharmaceuticals, Inc. Portfolio share: 2.17% Portfolio value: 7.62M Avg. open price: $3.38 Current price: $4.76 P/L: +40.62% Bought +1.20% shares Q3 2022	share	2.17%	7.62M	$3.38	$4.76	+40.62%	Bought +1.20% shares Q3 2022
Diagnostics & Research Waters Corporation Portfolio share: 2.12% Portfolio value: 7.44M Avg. open price: $330.98 Current price: $340.29 P/L: +2.81% Bought +5.26% shares Q3 2022	share	2.12%	7.44M	$330.98	$340.29	+2.81%	Bought +5.26% shares Q3 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 2.00% Portfolio value: 7.04M Avg. open price: $4.88 Current price: $5.61 P/L: +14.96% Bought +15.14% shares Q3 2022	share	2.00%	7.04M	$4.88	$5.61	+14.96%	Bought +15.14% shares Q3 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 1.92% Portfolio value: 6.76M Avg. open price: $69.11 Current price: $73.85 P/L: +6.86% N/A Q3 2022	share	1.92%	6.76M	$69.11	$73.85	+6.86%	N/A Q3 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 1.81% Portfolio value: 6.37M Avg. open price: $150.53 Current price: $211.93 P/L: +40.79% Sold -11.41% shares Q3 2022	share	1.81%	6.37M	$150.53	$211.93	+40.79%	Sold -11.41% shares Q3 2022
Drug Manufacturers—Specialty & Generic Deciphera Pharmaceuticals, Inc. Portfolio share: 1.59% Portfolio value: 5.58M Avg. open price: N/A Current price: $15.02 P/L: N/A N/A Q3 2022	share	1.59%	5.58M	N/A	$15.02	N/A	N/A Q3 2022
Health Information Services R1 RCM Inc. Portfolio share: 1.47% Portfolio value: 5.16M Avg. open price: $22.36 Current price: $10.11 P/L: -54.78% Bought +20.86% shares Q3 2022	share	1.47%	5.16M	$22.36	$10.11	-54.78%	Bought +20.86% shares Q3 2022
Biotechnology Legend Biotech Corporation Portfolio share: 1.41% Portfolio value: 4.94M Avg. open price: $55 Current price: $50.99 P/L: -7.29% Bought +2.90% shares Q3 2022	share	1.41%	4.94M	$55	$50.99	-7.29%	Bought +2.90% shares Q3 2022
Medical Devices Alphatec Holdings, Inc. Portfolio share: 1.35% Portfolio value: 4.76M Avg. open price: $9.44 Current price: $9.75 P/L: +3.34% Bought +4.09% shares Q3 2022	share	1.35%	4.76M	$9.44	$9.75	+3.34%	Bought +4.09% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 1.31% Portfolio value: 4.61M Avg. open price: $58.49 Current price: $40.39 P/L: -30.94% Bought +42.07% shares Q3 2022	share	1.31%	4.61M	$58.49	$40.39	-30.94%	Bought +42.07% shares Q3 2022
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 1.31% Portfolio value: 4.60M Avg. open price: N/A Current price: $27.14 P/L: N/A N/A Q3 2022	share	1.31%	4.60M	N/A	$27.14	N/A	N/A Q3 2022
Biotechnology Day One Biopharmaceuticals, Inc. Portfolio share: 1.21% Portfolio value: 4.25M Avg. open price: $17.9 Current price: $21.45 P/L: +19.83% Bought +84.92% shares Q3 2022	share	1.21%	4.25M	$17.9	$21.45	+19.83%	Bought +84.92% shares Q3 2022
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 1.19% Portfolio value: 4.19M Avg. open price: $32.69 Current price: $45.58 P/L: +39.43% Bought +7.09% shares Q3 2022	share	1.19%	4.19M	$32.69	$45.58	+39.43%	Bought +7.09% shares Q3 2022
Medical Devices Insulet Corporation Portfolio share: 1.11% Portfolio value: 3.91M Avg. open price: $214 Current price: $302.43 P/L: +41.32% Bought +22.79% shares Q3 2022	share	1.11%	3.91M	$214	$302.43	+41.32%	Bought +22.79% shares Q3 2022
Biotechnology Sutro Biopharma, Inc. Portfolio share: 1.08% Portfolio value: 3.81M Avg. open price: $6.94 Current price: $7.39 P/L: +6.55% Bought +272.50% shares Q3 2022	share	1.08%	3.81M	$6.94	$7.39	+6.55%	Bought +272.50% shares Q3 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 1.08% Portfolio value: 3.80M Avg. open price: N/A Current price: $557.21 P/L: N/A N/A Q3 2022	share	1.08%	3.80M	N/A	$557.21	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic ANI Pharmaceuticals, Inc. Portfolio share: 1.08% Portfolio value: 3.79M Avg. open price: $33.19 Current price: $37.98 P/L: +14.42% Bought +8.64% shares Q3 2022	share	1.08%	3.79M	$33.19	$37.98	+14.42%	Bought +8.64% shares Q3 2022
Biotechnology Keros Therapeutics, Inc. Portfolio share: 1.07% Portfolio value: 3.75M Avg. open price: $29.11 Current price: $50 P/L: +71.79% Bought +109.10% shares Q3 2022	share	1.07%	3.75M	$29.11	$50	+71.79%	Bought +109.10% shares Q3 2022
Diagnostics & Research Aclaris Therapeutics, Inc. Portfolio share: 1.05% Portfolio value: 3.67M Avg. open price: $1.8 Current price: $15.66 P/L: +771.31% Sold -23.36% shares Q3 2022	share	1.05%	3.67M	$1.8	$15.66	+771.31%	Sold -23.36% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 1.04% Portfolio value: 3.64M Avg. open price: N/A Current price: $103.53 P/L: N/A N/A Q3 2022	share	1.04%	3.64M	N/A	$103.53	N/A	N/A Q3 2022
Medical Devices Apollo Endosurgery, Inc. Portfolio share: 1.03% Portfolio value: 3.62M Avg. open price: $6.28 Current price: $9.99 P/L: +59.00% Bought +1.18% shares Q3 2022	share	1.03%	3.62M	$6.28	$9.99	+59.00%	Bought +1.18% shares Q3 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 1.03% Portfolio value: 3.60M Avg. open price: $29.4 Current price: $33.96 P/L: +15.52% Sold -19.46% shares Q3 2022	share	1.03%	3.60M	$29.4	$33.96	+15.52%	Sold -19.46% shares Q3 2022
Biotechnology Cogent Biosciences, Inc. Portfolio share: 1.00% Portfolio value: 3.53M Avg. open price: N/A Current price: $12.5 P/L: N/A Sold -18.03% shares Q3 2022	share	1.00%	3.53M	N/A	$12.5	N/A	Sold -18.03% shares Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 0.94% Portfolio value: 3.30M Avg. open price: N/A Current price: $13.57 P/L: N/A N/A Q3 2022	share	0.94%	3.30M	N/A	$13.57	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 0.93% Portfolio value: 3.27M Avg. open price: $130.97 Current price: $50.77 P/L: -61.24% Sold -33.00% shares Q3 2022	share	0.93%	3.27M	$130.97	$50.77	-61.24%	Sold -33.00% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.92% Portfolio value: 3.25M Avg. open price: $327.22 Current price: $116.56 P/L: -64.38% Bought +15.86% shares Q3 2022	share	0.92%	3.25M	$327.22	$116.56	-64.38%	Bought +15.86% shares Q3 2022
Medical Devices iRhythm Technologies, Inc. Portfolio share: 0.91% Portfolio value: 3.18M Avg. open price: $93.13 Current price: $102.75 P/L: +10.33% Sold -65.60% shares Q3 2022	share	0.91%	3.18M	$93.13	$102.75	+10.33%	Sold -65.60% shares Q3 2022
Medical Instruments & Supplies NanoString Technologies, Inc. Portfolio share: 0.88% Portfolio value: 3.09M Avg. open price: N/A Current price: $7.06 P/L: N/A N/A Q3 2022	share	0.88%	3.09M	N/A	$7.06	N/A	N/A Q3 2022
Health Information Services Schrödinger, Inc. Portfolio share: 0.88% Portfolio value: 3.09M Avg. open price: $52.27 Current price: $16.48 P/L: -68.47% Bought +1.19% shares Q3 2022	share	0.88%	3.09M	$52.27	$16.48	-68.47%	Bought +1.19% shares Q3 2022
Drug Manufacturers—Specialty & Generic Supernus Pharmaceuticals, Inc. Portfolio share: 0.86% Portfolio value: 3.03M Avg. open price: $28.4 Current price: $35.61 P/L: +25.38% Bought +1.19% shares Q3 2022	share	0.86%	3.03M	$28.4	$35.61	+25.38%	Bought +1.19% shares Q3 2022
Biotechnology MannKind Corporation Portfolio share: 0.81% Portfolio value: 2.85M Avg. open price: $4.06 Current price: $4.61 P/L: +13.46% Bought +20.94% shares Q3 2022	share	0.81%	2.85M	$4.06	$4.61	+13.46%	Bought +20.94% shares Q3 2022
Biotechnology Imago BioSciences, Inc. Portfolio share: 0.81% Portfolio value: 2.84M Avg. open price: $17.72 Current price: $35.86 P/L: +102.36% Bought +28.36% shares Q3 2022	share	0.81%	2.84M	$17.72	$35.86	+102.36%	Bought +28.36% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 0.80% Portfolio value: 2.81M Avg. open price: N/A Current price: $269.72 P/L: N/A N/A Q3 2022	share	0.80%	2.81M	N/A	$269.72	N/A	N/A Q3 2022
Medical Instruments & Supplies The Cooper Companies, Inc. Portfolio share: 0.80% Portfolio value: 2.80M Avg. open price: $387.55 Current price: $321.56 P/L: -17.03% Bought +1.16% shares Q3 2022	share	0.80%	2.80M	$387.55	$321.56	-17.03%	Bought +1.16% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 0.79% Portfolio value: 2.79M Avg. open price: $66.03 Current price: $56.01 P/L: -15.17% Bought +85.20% shares Q3 2022	share	0.79%	2.79M	$66.03	$56.01	-15.17%	Bought +85.20% shares Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.77% Portfolio value: 2.69M Avg. open price: N/A Current price: $226.95 P/L: N/A N/A Q3 2022	share	0.77%	2.69M	N/A	$226.95	N/A	N/A Q3 2022
Biotechnology Arcellx, Inc. Portfolio share: 0.75% Portfolio value: 2.62M Avg. open price: N/A Current price: $19.45 P/L: N/A Sold -21.42% shares Q3 2022	share	0.75%	2.62M	N/A	$19.45	N/A	Sold -21.42% shares Q3 2022
Medical Devices AxoGen, Inc. Portfolio share: 0.68% Portfolio value: 2.38M Avg. open price: $11.6 Current price: $10.93 P/L: -5.75% Bought +6.10% shares Q3 2022	share	0.68%	2.38M	$11.6	$10.93	-5.75%	Bought +6.10% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.62% Portfolio value: 2.17M Avg. open price: $133.8 Current price: $226.4 P/L: +69.21% Sold -47.56% shares Q3 2022	share	0.62%	2.17M	$133.8	$226.4	+69.21%	Sold -47.56% shares Q3 2022
Biotechnology Immunic, Inc. Portfolio share: 0.59% Portfolio value: 2.07M Avg. open price: $11.83 Current price: $1.34 P/L: -88.67% Bought +1.17% shares Q3 2022	share	0.59%	2.07M	$11.83	$1.34	-88.67%	Bought +1.17% shares Q3 2022
Medical Devices RxSight, Inc. Portfolio share: 0.57% Portfolio value: 2.00M Avg. open price: $14.08 Current price: $13.83 P/L: -1.78% Bought +45.01% shares Q3 2022	share	0.57%	2.00M	$14.08	$13.83	-1.78%	Bought +45.01% shares Q3 2022
Drug Manufacturers—Specialty & Generic Esperion Therapeutics, Inc. Portfolio share: 0.56% Portfolio value: 1.98M Avg. open price: N/A Current price: $7.49 P/L: N/A N/A Q3 2022	share	0.56%	1.98M	N/A	$7.49	N/A	N/A Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.54% Portfolio value: 1.90M Avg. open price: $14.72 Current price: $6.56 P/L: -55.44% Sold -10.39% shares Q3 2022	share	0.54%	1.90M	$14.72	$6.56	-55.44%	Sold -10.39% shares Q3 2022
Medical Instruments & Supplies Akoya Biosciences, Inc. Portfolio share: 0.54% Portfolio value: 1.9M Avg. open price: $12.54 Current price: $12.55 P/L: +0.08% Sold -12.49% shares Q3 2022	share	0.54%	1.9M	$12.54	$12.55	+0.08%	Sold -12.49% shares Q3 2022
Specialty Business Services Performant Financial Corporation Portfolio share: 0.54% Portfolio value: 1.89M Avg. open price: $3.46 Current price: $2.37 P/L: -31.50% Bought +1.19% shares Q3 2022	share	0.54%	1.89M	$3.46	$2.37	-31.50%	Bought +1.19% shares Q3 2022
Biotechnology Bicycle Therapeutics plc Portfolio share: 0.54% Portfolio value: 1.89M Avg. open price: $22.05 Current price: $32.41 P/L: +46.96% Bought +34.65% shares Q3 2022	share	0.54%	1.89M	$22.05	$32.41	+46.96%	Bought +34.65% shares Q3 2022
Drug Manufacturers—Specialty & Generic Landec Corporation Portfolio share: 0.51% Portfolio value: 1.79M Avg. open price: $10.09 Current price: $8.76 P/L: -13.15% Bought +66.30% shares Q3 2022	share	0.51%	1.79M	$10.09	$8.76	-13.15%	Bought +66.30% shares Q3 2022
Medical Devices TransMedics Group, Inc. Portfolio share: 0.50% Portfolio value: 1.76M Avg. open price: N/A Current price: $61.9 P/L: N/A N/A Q3 2022	share	0.50%	1.76M	N/A	$61.9	N/A	N/A Q3 2022
Biotechnology X4 Pharmaceuticals, Inc. Portfolio share: 0.46% Portfolio value: 1.62M Avg. open price: N/A Current price: $1.29 P/L: N/A N/A Q3 2022	share	0.46%	1.62M	N/A	$1.29	N/A	N/A Q3 2022
Biotechnology Kiniksa Pharmaceuticals, Ltd. Portfolio share: 0.46% Portfolio value: 1.62M Avg. open price: $12.82 Current price: $15.73 P/L: +22.69% Bought +1.19% shares Q3 2022	share	0.46%	1.62M	$12.82	$15.73	+22.69%	Bought +1.19% shares Q3 2022
Medical Instruments & Supplies KORU Medical Systems, Inc. Portfolio share: 0.43% Portfolio value: 1.52M Avg. open price: $4.48 Current price: $3.27 P/L: -26.95% Bought +1.19% shares Q3 2022	share	0.43%	1.52M	$4.48	$3.27	-26.95%	Bought +1.19% shares Q3 2022
Biotechnology Madrigal Pharmaceuticals, Inc. Portfolio share: 0.40% Portfolio value: 1.40M Avg. open price: $92.2 Current price: $72.87 P/L: -20.96% Bought +1.19% shares Q3 2022	share	0.40%	1.40M	$92.2	$72.87	-20.96%	Bought +1.19% shares Q3 2022
Biotechnology Liquidia Corporation Portfolio share: 0.39% Portfolio value: 1.38M Avg. open price: N/A Current price: $5.18 P/L: N/A N/A Q3 2022	share	0.39%	1.38M	N/A	$5.18	N/A	N/A Q3 2022
Biotechnology 89bio, Inc. Portfolio share: 0.37% Portfolio value: 1.30M Avg. open price: $22.39 Current price: $8.34 P/L: -62.75% N/A Q3 2022	share	0.37%	1.30M	$22.39	$8.34	-62.75%	N/A Q3 2022
Biotechnology Silence Therapeutics plc Portfolio share: 0.36% Portfolio value: 1.27M Avg. open price: $11.85 Current price: $17.09 P/L: +44.22% Bought +385.55% shares Q3 2022	share	0.36%	1.27M	$11.85	$17.09	+44.22%	Bought +385.55% shares Q3 2022
Biotechnology Veracyte, Inc. Portfolio share: 0.29% Portfolio value: 1.01M Avg. open price: $38.23 Current price: $27.17 P/L: -28.93% Sold -17.69% shares Q3 2022	share	0.29%	1.01M	$38.23	$27.17	-28.93%	Sold -17.69% shares Q3 2022
Medical Devices Beyond Air, Inc. Portfolio share: 0.27% Portfolio value: 941K Avg. open price: N/A Current price: $5.92 P/L: N/A N/A Q3 2022	share	0.27%	941K	N/A	$5.92	N/A	N/A Q3 2022
Medical Devices TELA Bio, Inc. Portfolio share: 0.27% Portfolio value: 940K Avg. open price: $12.14 Current price: $8.6 P/L: -29.14% Bought +1.19% shares Q3 2022	share	0.27%	940K	$12.14	$8.6	-29.14%	Bought +1.19% shares Q3 2022
Biotechnology PepGen Inc. Portfolio share: 0.26% Portfolio value: 908K Avg. open price: N/A Current price: $14.98 P/L: N/A N/A Q3 2022	share	0.26%	908K	N/A	$14.98	N/A	N/A Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.26% Portfolio value: 897K Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q3 2022	share	0.26%	897K	N/A	$21.89	N/A	N/A Q3 2022
Biotechnology Mirum Pharmaceuticals, Inc. Portfolio share: 0.25% Portfolio value: 891K Avg. open price: $19.81 Current price: $18.33 P/L: -7.48% Bought +32.43% shares Q3 2022	share	0.25%	891K	$19.81	$18.33	-7.48%	Bought +32.43% shares Q3 2022
Medical Devices Establishment Labs Holdings Inc. Portfolio share: 0.24% Portfolio value: 829K Avg. open price: N/A Current price: $68.77 P/L: N/A N/A Q3 2022	share	0.24%	829K	N/A	$68.77	N/A	N/A Q3 2022
Biotechnology Opiant Pharmaceuticals, Inc. Portfolio share: 0.23% Portfolio value: 823K Avg. open price: $21.68 Current price: $20.22 P/L: -6.73% Bought +1.19% shares Q3 2022	share	0.23%	823K	$21.68	$20.22	-6.73%	Bought +1.19% shares Q3 2022
Medical Instruments & Supplies Harvard Bioscience, Inc. Portfolio share: 0.22% Portfolio value: 782K Avg. open price: $7.49 Current price: $2.84 P/L: -62.06% Sold -13.19% shares Q3 2022	share	0.22%	782K	$7.49	$2.84	-62.06%	Sold -13.19% shares Q3 2022
Biotechnology Lexicon Pharmaceuticals, Inc. Portfolio share: 0.21% Portfolio value: 729K Avg. open price: $1.86 Current price: $2.16 P/L: +16.13% Bought +21.45% shares Q3 2022	share	0.21%	729K	$1.86	$2.16	+16.13%	Bought +21.45% shares Q3 2022
Biotechnology Viridian Therapeutics, Inc. Portfolio share: 0.21% Portfolio value: 725K Avg. open price: N/A Current price: $26.84 P/L: N/A N/A Q3 2022	share	0.21%	725K	N/A	$26.84	N/A	N/A Q3 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 0.19% Portfolio value: 655K Avg. open price: $24.23 Current price: $20.01 P/L: -17.42% Bought +1.20% shares Q3 2022	share	0.19%	655K	$24.23	$20.01	-17.42%	Bought +1.20% shares Q3 2022
Biotechnology Codexis, Inc. Portfolio share: 0.18% Portfolio value: 638K Avg. open price: $22.9 Current price: $5.93 P/L: -74.10% Sold -48.39% shares Q3 2022	share	0.18%	638K	$22.9	$5.93	-74.10%	Sold -48.39% shares Q3 2022
Biotechnology Plus Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 590K Avg. open price: $1 Current price: $0.39 P/L: -61.00% Sold -13.57% shares Q3 2022	share	0.17%	590K	$1	$0.39	-61.00%	Sold -13.57% shares Q3 2022
Biotechnology Edgewise Therapeutics, Inc. Portfolio share: 0.14% Portfolio value: 492K Avg. open price: N/A Current price: $8.83 P/L: N/A N/A Q3 2022	share	0.14%	492K	N/A	$8.83	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Alpha Teknova, Inc. Portfolio share: 0.12% Portfolio value: 406K Avg. open price: $22.66 Current price: $4.76 P/L: -79.00% Bought +1.19% shares Q3 2022	share	0.12%	406K	$22.66	$4.76	-79.00%	Bought +1.19% shares Q3 2022
Diagnostics & Research Neuronetics, Inc. Portfolio share: 0.08% Portfolio value: 273K Avg. open price: N/A Current price: $6.2 P/L: N/A N/A Q3 2022	share	0.08%	273K	N/A	$6.2	N/A	N/A Q3 2022
Biotechnology BioLineRx Ltd. Portfolio share: 0.08% Portfolio value: 267K Avg. open price: $2.72 Current price: $0.73 P/L: -73.32% Bought +1.19% shares Q3 2022	share	0.08%	267K	$2.72	$0.73	-73.32%	Bought +1.19% shares Q3 2022
Medical Devices Sientra, Inc. Portfolio share: 0.07% Portfolio value: 239K Avg. open price: $6.71 Current price: $0.27 P/L: -95.92% Sold -10.88% shares Q3 2022	share	0.07%	239K	$6.71	$0.27	-95.92%	Sold -10.88% shares Q3 2022
Biotechnology Unity Biotechnology, Inc. Portfolio share: 0.05% Portfolio value: 160K Avg. open price: N/A Current price: $2.93 P/L: N/A N/A Q3 2022	share	0.05%	160K	N/A	$2.93	N/A	N/A Q3 2022
Biotechnology Forma Therapeutics Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $14.44 Current price: $20.01 P/L: +38.57% Sold -100.00% shares Q3 2022	share	0.00%	0	$14.44	$20.01	+38.57%	Sold -100.00% shares Q3 2022
Biotechnology Phathom Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $13.61 Current price: $11.07 P/L: -18.66% Sold -100.00% shares Q3 2022	share	0.00%	0	$13.61	$11.07	-18.66%	Sold -100.00% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $15.86 Current price: $19.03 P/L: +19.99% Sold -100.00% shares Q3 2022	share	0.00%	0	$15.86	$19.03	+19.99%	Sold -100.00% shares Q3 2022
Biotechnology Surface Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.84 Current price: $0.91 P/L: -88.36% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.84	$0.91	-88.36%	Sold -100.00% shares Q3 2022
Specialty Chemicals Avantor, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $30.76 Current price: $22.35 P/L: -27.35% Sold -100.00% shares Q3 2022	share	0.00%	0	$30.76	$22.35	-27.35%	Sold -100.00% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.63 Current price: $11.09 P/L: +45.33% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.63	$11.09	+45.33%	Sold -100.00% shares Q3 2022
Biotechnology Eiger BioPharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.3 Current price: $4.14 P/L: -50.12% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.3	$4.14	-50.12%	Sold -100.00% shares Q3 2022
Biotechnology Allakos Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $5.7 Current price: $8.14 P/L: +42.72% Sold -100.00% shares Q3 2022	share	0.00%	0	$5.7	$8.14	+42.72%	Sold -100.00% shares Q3 2022
Health Information Services Health Catalyst, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $41.26 Current price: $10.84 P/L: -73.73% Sold -100.00% shares Q3 2022	share	0.00%	0	$41.26	$10.84	-73.73%	Sold -100.00% shares Q3 2022
Biotechnology Zymeworks Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.09 Current price: $7.62 P/L: -55.40% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.09	$7.62	-55.40%	Sold -100.00% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.4 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.4	N/A	Sold -100.00% shares Q3 2022

Showing TOP 100 PARKMAN HEALTHCARE PARTNERS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of PARKMAN HEALTHCARE PARTNERS LLC?

The biggest position of the PARKMAN HEALTHCARE PARTNERS LLC is United Therapeutics Corporation (UTHR) with 4.9% portfolio share worth of 17.23M US dollars.

Top 5 PARKMAN HEALTHCARE PARTNERS's holdings represent 20.13% of the portfolio:

United Therapeutics Corporation (UTHR) – 4.9%
UnitedHealth Group Incorporated (UNH) – 3.97%
Danaher Corporation (DHR) – 3.89%
Boston Scientific Corporation (BSX) – 3.83%
Neurocrine Biosciences, Inc. (NBIX) – 3.55%

Who is the portfolio manager of PARKMAN HEALTHCARE PARTNERS LLC?

The portfolio manager of the PARKMAN HEALTHCARE PARTNERS LLC is .

What is the total asset value of the PARKMAN HEALTHCARE PARTNERS LLC portfolio?

PARKMAN HEALTHCARE PARTNERS LLC total asset value (portfolio value) is 351.74M US dollars.

Who is ?

is the portfolio manager of the PARKMAN HEALTHCARE PARTNERS LLC.

What is (PARKMAN HEALTHCARE PARTNERS LLC) fund performance?

PARKMAN HEALTHCARE PARTNERS's quarterly performance is +0.78%, annualy -32.84%.

What is the PARKMAN HEALTHCARE PARTNERS LLC CIK?

PARKMAN HEALTHCARE PARTNERS's Central Index Key is 0001777015 .